Ecolab

Custom Supply Corp, based in Providence, RI, was a trusted media equipment and supply source for the production community for 27 years until its closure in 2013. Offering a wide range of product lines from renowned brands, they provided sound advice, reasonable prices, and a no-nonsense approach to customers in various industries, including news, broadcast production, cinematography, corporate video, religious production, and government, education, or event videography. With a dedicated and knowledgeable staff, Custom Supply Corp was known for its extensive line listing and commitment to delivering the right equipment at the right price. Their retirement marked the end of an era, leaving behind a legacy of exceptional service and gratitude to their customers for the opportunity to be part of their fascinating work.Generated from the website

Fraser Molloy & Associates is a reputable company based in Charlestown, MA, specializing in the supply of high-quality weld studs, equipment, and accessories. With a wide range of products including inverter welders, weld guns, and automated systems, they cater to the needs of various industries, offering rentals and services to ensure efficient and reliable welding solutions. Known for their heavy-duty ferrule grips, such as the GH-100, Fraser Molloy & Associates is committed to providing top-notch products that meet the highest standards. With their expertise and dedication, they have established themselves as a trusted source for welding equipment, serving clients with professionalism and excellence.Generated from the website

Cequent Pharmaceuticals, a privately held biopharmaceutical company based in Cambridge, Massachusetts, is at the forefront of developing novel therapeutics aimed at preventing and treating a variety of human diseases, including inflammatory diseases and cancer. Established in 2006, the company leverages its proprietary TransKingdom RNA interference (tkRNAi) technology to target specific disease-causing genes safely and effectively using non-pathogenic bacteria as delivery vehicles. The tkRNAi platform enables the development of drug candidates that can silence one or more cellular genes simultaneously, offering a powerful alternative to traditional small molecules and monoclonal antibodies. With its foundation rooted in groundbreaking scientific research from the Institut Pasteur in Paris and Beth Israel Deaconess Medical Center at Harvard Medical School, Cequent is poised to make significant advancements in the biopharmaceutical landscape. Generated from the website